Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT05679921
Recruiting
Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma
Phase 2 · South Korea · 1 site
Registry update: 16 Jul 2025
NCT06387485
Recruiting
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
Not applicable · United States · 3 sites
Registry update: 6 Feb 2026
NCT05926700
Recruiting
Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment
Phase 2 · China · 1 site
Registry update: 8 Apr 2026
NCT05500391
Recruiting
Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Phase 2 · France · 3 sites
Registry update: 18 Mar 2026
NCT06277154
Recruiting
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Phase 2 · China · 1 site
Registry update: 24 Jul 2025
NCT06064682
Recruiting
An Organoid-based Functional Precision Medicine Trial in Osteosarcoma
Not applicable · United States · 1 site
Registry update: 11 May 2026
NCT05868629
Recruiting
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
Not applicable · United States · 8 sites
Registry update: 1 Apr 2026
NCT05711615
Recruiting
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Phase 1 · United States · 16 sites
Registry update: 4 Nov 2026
NCT06113809
Recruiting
Palbociclib and Pembrolizumab in Sarcoma
Phase 1 · United States · 1 site
Registry update: 22 May 2026
NCT07048249
Recruiting
Single Arm Romiplostim to Prevent CIT
Early phase 1 · United States · 2 sites
Registry update: 18 Mar 2026
NCT06279130
Recruiting
Pan-tumor neoadjuvant basket study of immune check-point inhibition and novel IO combinations (NEOASIS)
Phase 2 · Netherlands · 1 site
Registry update: 21 Oct 2026
NCT06243588
Recruiting
Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma
Not applicable · Italy · 1 site
Registry update: 5 Mar 2025
NCT06111612
Recruiting
Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement
Not applicable · China · 1 site
Registry update: 22 Jul 2024
NCT05999396
Recruiting
FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer
Phase 1 · Germany · 1 site
Registry update: 21 May 2025
NCT06324916
Recruiting
Donor Site Morbidity After Free Vascularized Fibular Graft
Not applicable · Egypt · 1 site
Registry update: 22 Mar 2024
2024-513514-35-00
Recruiting
Trial to evaluate CAR-T NKG2D CAR cell infusions in patients with advanced sarcoma
Phase 1 · Spain · 1 site
Registry update: 24 Jul 2026
NCT06087341
Recruiting
A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma
Phase 1 · Spain · 1 site
Registry update: 12 Apr 2024
NCT06236022
Recruiting
The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Phase 4 · China · 1 site
Registry update: 1 Feb 2024
NCT06778603
Recruiting
B7-H3 NIR Imaging for Osteosarcoma Surgery
Phase 1/2 · China · 1 site
Registry update: 16 Jan 2025
NCT05457829
Recruiting
Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study
Phase 2 · China · 1 site
Registry update: 18 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.